Gene description for BCAM |
Gene name |
basal cell adhesion molecule (Lutheran blood group) |
Gene symbol |
BCAM |
Other names/aliases |
AU B-CAM CD239 F8/G253 LU MSK19 |
Species |
Homo sapiens |
Experiment description of studies that identified BCAM in Prostate cancer cells |
1
|
Experiment ID | 851 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP - in CSS - Rep 1 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
2
|
Experiment ID | 852 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP - in CSS - Rep 2 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
3
|
Experiment ID | 855 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP - in CSS with DHT treatment - Rep 1 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
4
|
Experiment ID | 856 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP - in CSS with DHT treatment - Rep 2 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
5
|
Experiment ID | 857 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP - in CSS with DHT treatment - Rep 3 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
6
|
Experiment ID | 963 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
25844599
|
Organism | Homo sapiens |
Experiment description | Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors | Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, UlléA, Yachnin J, Nilsson S, Panaretakis T. |
Journal name |
Oncotarget
|
Publication year | 2015 |
Sample | Prostate cancer cells |
Sample name | DU145 Tax-Sen |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | 1.12-1.19 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV150027: EV-METRIC:11%, 56%
|
|
|
7
|
Experiment ID | 964 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
25844599
|
Organism | Homo sapiens |
Experiment description | Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. |
Authors | Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, UlléA, Yachnin J, Nilsson S, Panaretakis T. |
Journal name |
Oncotarget
|
Publication year | 2015 |
Sample | Prostate cancer cells |
Sample name | DU145 Tax-Res |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | 1.13-1.18 g/mL |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV150027: EV-METRIC:11%, 56%
|
|
|
8
|
Experiment ID | 1111 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
24391718
|
Organism | Homo sapiens |
Experiment description | Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. |
Authors | Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pa.a-Toli. L, Jenster G. |
Journal name |
PLoS One
|
Publication year | 2013 |
Sample | Prostate cancer cells |
Sample name | PC346C- replicate 2 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV130038: EV-METRIC:33%
|
|
|
9
|
Experiment ID | 1113 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
24391718
|
Organism | Homo sapiens |
Experiment description | Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. |
Authors | Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pa.a-Toli. L, Jenster G. |
Journal name |
PLoS One
|
Publication year | 2013 |
Sample | Prostate cancer cells |
Sample name | VCaP- replicate 1 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV130038: EV-METRIC:33%
|
|
|
10
|
Experiment ID | 1114 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
24391718
|
Organism | Homo sapiens |
Experiment description | Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. |
Authors | Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pa.a-Toli. L, Jenster G. |
Journal name |
PLoS One
|
Publication year | 2013 |
Sample | Prostate cancer cells |
Sample name | VCaP- replicate 2 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV130038: EV-METRIC:33%
|
|
|
11
|
Experiment ID | 1115 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
24391718
|
Organism | Homo sapiens |
Experiment description | Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. |
Authors | Duijvesz D, Burnum-Johnson KE, Gritsenko MA, Hoogland AM, Vredenbregt-van den Berg MS, Willemsen R, Luider T, Pa.a-Toli. L, Jenster G. |
Journal name |
PLoS One
|
Publication year | 2013 |
Sample | Prostate cancer cells |
Sample name | VCaP- replicate 3 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation Density gradient centrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry |
EV-TRACK |
EV130038: EV-METRIC:33%
|
|
|
12
|
Experiment ID | 1194 |
Identified molecule | protein
|
Extracellular vesicle type | Extracellular vesicles |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
28881726
|
Organism | Homo sapiens |
Experiment description | Modulation of paracrine signaling by CD9 positive small extracellular vesicles mediates cellular growth of androgen deprived prostate cancer. |
Authors | Soekmadji C, Riches JD, Russell PJ, Ruelcke JE, McPherson S, Wang C, Hovens CM, Corcoran NM; Australian Prostate Cancer Collaboration BioResource, Hill MM, Nelson CC. |
Journal name |
Oncotarget.
|
Publication year | 2016 |
Sample | Prostate cancer cells |
Sample name | DUCaP, DHT treatment |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV170047: EV-METRIC:44%, 0%, 44%, 44%, 44%, 33%, 33%, 33%
|
|
|
13
|
Experiment ID | 1261 |
Identified molecule | protein
|
Extracellular vesicle type | Exosomes |
MISEV | EVs |
Identification method | Mass spectrometry
|
PubMed ID |
24371517
|
Organism | Homo sapiens |
Experiment description | Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. |
Authors | Bijnsdorp IV, Geldof AA, Lavaei M, Piersma SR, van Moorselaar RJ, Jimenez CR. |
Journal name |
J Extracell Vesicles.
|
Publication year | 2013 |
Sample | Prostate cancer cells |
Sample name | PC3 |
Isolation/purification methods | Differential centrifugation Ultracentrifugation |
Flotation density | - |
Molecules identified in the study | Protein |
Methods used in the study | Mass spectrometry Western blotting |
EV-TRACK |
EV130168: EV-METRIC:11%, 11%
|
|
|